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Abstract.  CD20 is a  plasma membrane phosphopro- 
tein expressed exclusively by B lymphocytes, mAb 
binding to CD20 alters cell cycle progression and dif- 
ferentiation, indicating that CD20 plays an essential 
role in B lymphocyte function. Whole-cell patch clamp 
and fluorescence microscopy measurements of plasma 
membrane ionic conductance and cytosolic-free Ca  2÷ 
activity, respectively, were used to directly examine 
CD20 function. Transfection of human T  and mouse 
pre-B lymphoblastoid cell lines with CD20 cDNA and 
subsequent stable expression of CD20 specifically in- 
creased transmembrane Ca  2+ conductance. Transfection 
of CD20 cDNA and subsequent expression of CD20 
in nonlymphoid cells (human K562 erythroleukemia 
cells and mouse NIH-3T3 fibroblasts) also induced the 
expression of an identical transmembrane Ca  2÷ con- 
ductance. The binding of a  CD20-specific mAb to 
CD20  ÷ lymphoblastoid cells also enhanced the trans- 
membrane Ca  2÷ conductance. The mAb-enhanced Ca  2+ 
currents had the same conductance characteristics as 
the CD20-associated Ca  2÷ currents in CD20 cDNA- 
transfected cells. C20 is structurally similar to several 
ion channels; each CD20 monomer possesses four 
membrane spanning domains, and both the amino and 
carboxy termini reside within the cytoplasm. Bio- 
chemical cross-linking of cell-surface molecules with 
subsequent immunoprecipitation analysis of CD20 sug- 
gests that CD20 may be present as a  multimeric oli- 
gomer within the membrane, as occurs with several 
known membrane channels. Taken together, these find- 
ings indicate that CD20 directly regulates transmem- 
brane Ca  2÷ conductance in B lymphocytes, and suggest 
that multimeric complexes of CD20 may form Ca  2÷ 
conductive ion channels in the plasma membrane of B 
lymphoid cells. 
C 
D20 was among the first lineage-specific differentia- 
tion antigens to be identified on human B lympho- 
cytes, after surface Ig (43). CD20 is found on the cell 
surface of early B cell precursors and all mature B cells, and 
it is lost with differentiation into plasma cells (33,  38, 43, 
44). The specific function of CD20 has not been previously 
elucidated,  however,  CD20  function has  been  associated 
with cell cycle progression, mAb binding to CD20 inhibits 
B lymphocyte progression into the S/G2+M stages of cell 
cycle following mitogen stimulation (15, 50, 51), and also in- 
hibits B lymphocyte differentiation and Epstein-Barr virus- 
and pokeweed  mitogen-induced Ig  secretion  (15, 19,  20, 
50, 51). Additionally, one CD20 mAb (1F5) that binds to a 
unique CD20 epitope (10, 48) is capable of activating dense 
tonsilar (Go) B lymphocytes (10, 20, 40). CD20 is not phos- 
phorylated in resting B cells, but becomes heavily phosphor- 
ylated after mitogen stimulation, providing further evidence 
that CD20 is involved in B cell activation and differentiation 
(47, 57). CD20 is a dominant phosphoprotein in activated B 
cells, B cell lines, and Hairy cell leukemias (17, 47). In addi- 
tion, mAb binding to CD20 generates a transmembrane sig- 
nal that results in enhanced phosphorylation of the molecule 
(47), initiation of tyrosine-kinase activity (26) and induction 
ofc-myc oncogene expression (40). The effects ofmAb bind- 
ing are thought to be consequences of altered CD20 function 
and therefore indicate that CD20 plays a role in B lympho- 
cyte activation, proliferation, and differentiation. 
CD20 is a structurally unique protein that contains three 
extensive hydrophobic regions of sutlicient lengths to pass 
through the membrane four times (13, 42, 52, 54). The long 
carboxy- and amino-terminal ends of the molecule are lo- 
cated within the cytoplasm with only a minor portion of the 
molecule exposed  to  the  extracellular environment.  The 
transmembrane and cytoplasmic regions of both mouse and 
human CD20 are well conserved and may allow for interac- 
tions with multiple proteins that are co-immunoprecipitated 
with CD20 (35, 53).  Three forms of CD20 (33,000,  35,000, 
and 37,000 Mr) result from differential phosphorylation of a 
single  protein  species  at  different  serine  and  threonine 
residues  within the  cytoplasmic domains  (47, 53).  PMA 
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form  and  a  proportional  increase  in  the  amount  of the 
35,000-37,000-Mr forms (47), suggesting that phosphoryla- 
tion may be one molecular mechanism which regulates CD20 
function (47,  57). 
CD20  shares  a  common chromosomal location,  and  a 
similar overall structure and sequence homologies with the 
chain of the high affinity IgE receptor (FceRI) found on 
mast cells and basophilic leukemia cells (25,  52, 55). This 
suggests that CD20 and the FceRI/3 chain are members of 
a single gene family. Although, IgE-mediated degranulation 
of mast cells does not appear to require opening of ion chan- 
nels (32), the FceRI complex has long been associated with 
plasma  membrane  Ca  2÷  conductance,  because  antigenic 
cross-linking of receptors induces a  transient  increase in 
cytosolic-free Ca  2+  (58)  which  is  associated  with  a  net 
influx of Ca  2+ into the cells probably through Ca  2÷ channels 
(32,  37).  Reconstitution of the  FceRI complex into  lipid 
bilayers produced Ca  2+ channel activity and  suggests that 
the ~ subunit may constitute the pore-forming component of 
the receptor complex (11). The predicted structure of CD20 
suggests that it may also function as a channel, since multiple 
membrane-spanning domains and phosphorylation sites on 
the cytoplasmic domains are hallmarks of ligand-gated ion 
channels and other channel forming molecules (30, 60). The 
sequence homology within the transmembrane domains of 
CD20 and FceRI/3 chain suggest that these proteins may rep- 
resent a  unique  family of proteins  which  function either 
directly as ligand-gated ion channels or as essential compo- 
nents of such channels. 
The expression of CD20 in heterologous cells transfected 
with CD20 cDNA allowed us to directly test the hypothesis 
that CD20 mediates a plasma membrane ionic conductance 
in B lymphocytes. Minimally, the findings demonstrate that 
CD20 plays a direct role in the regulation of transmembrane 
conductive Ca  2+ flux, which elucidates a function for CD20 
and provides a mechanistic explanation for the role of CD20 
as a regulator of B lymphocyte activation and proliferation. 
The findings also support the hypothesis that CD20 is itself 
a Ca  2+ channel, but they do not rule out the possibility that 
CD20 may be an essential regulatory element in a heterolo- 
gous oligomer complex which functions as an ion channel. 
Materials and Methods 
CD20 cDNA Transfection of Cell Lines 
The human CD20 cDNA clone pBI-21 (54) was cloned into the BamHI site 
of the retroviral vector pZipNeoSV(X) (8) so that the 5' end of the cDNA 
coincided with that of the transcripts originating from the promoter in the 
long terminal repeat. This plasmid was named pZip.HuB1. Cell lines which 
do not endogenously express CD20 (Jurkat, Rex, 300.19,  K562, and NIH- 
3T3 cells) were grown in RPMI 1640 medium (GIBCO BRL, Gaithersburg, 
MD)  supplemented with  10%  FCS (Hyclone Labs, Logan, LIT), 2  mM 
L-glutamine, 50 U/ml penicillin, and 50/~g/ml streptomycin. Cells from 
each line were transfected with the pZipNeoSV(X) vector alone (controls) 
or pZip.HuB1 using the Cell-Porator Electroporation system (Bethesda Re- 
search Laboratories, Galthersburg, MD). The parameters for electropora- 
tion were:  100/~g of plasmid DNA per 5  x  106 cells in 0.5 mi of DME 
medium (GIBCO BRL) on ice, 1.6 millifarads, 250 V/0.4 cm, using the high 
ohm setting. Transfected cells were selected for using medium with I mg/ml 
Geneticin (GIBCO BRL) added. Jurkat clones expressing CD20 (Jurkat- 
CD20) were isolated by limiting dilution of  the cell population. CD20 posi- 
tive Rex (Rex-CD20),  300.19  (300.19-CD20),  K562  (K562-CD20),  and 
NIH-3T3 (NIH-3T3-CD20) transfected cells were isolated by panning on 
culture dishes coated with the anti-Bla (CD20) mAb, and therefore were 
oligoclonal. In all cases t>95% of the cells were CD20  + as determined by 
indirect immunofluorescence staining with flow cytometry analysis. The 
surface antigen phenotypes of the transfected human cells were examined 
using mAb reactive with surface lg, class I and class II major histocompati- 
bility antigens, CD2, CD3, CD4, CD8, CD15, CD19, CD20, CD21, CD24, 
CDw29, CD38, CD40, CD45, CD45RA, and CD56. The mouse pre-B cell 
line 300.19  was examined for surface lg and human CD20 expression. 
Antibodies and Flow Cytometry Analysis 
The CD20  mAb used in these studies were the anti-Bla (IgG2a)  mAb 
(provided by Dr. Lee Nadler, Dana-Farber Cancer Institute, Boston, MA) 
as described (43), and the 1F5 rnAb (IgG2a) mAb (provided by Dr. Edward 
Clark,  Seattle  University,  Seattle,  WA)  as  described (10).  The  CD21- 
specific mAb, HB-5 (IgG2a) was as described (49). The anti-Bla and HB-5 
mAb were purified by salt precipitation followed by anion-exchange chro- 
matography. The 1F5 mAb was purified by protein A affinity chromatogra- 
phy. All of the mAb were used in PBS. The anti-MHC class I mAb, W6/32, 
was used as ascites fluid (3). 
Indirect immunofluorescence analysis was carried out after washing the 
cells three times. Suspensions of viable cells were analyzed for surface anti- 
gen expression by incubation for 20 rain on ice with the appropriate inAb 
as ascites fluid diluted to the optimal concentration for immunostaining. Af- 
ter washing, the cells were treated for 20 rain at 4°C with FITC-conjugated 
goat anti-mouse Ig antibodies (Southern Biotechnology Associates, Bir- 
mingham, AL). Single color irnmunofluorescence analysis was performed 
on an Epics Profile flow cytometer (Coulter Electronics, Hialeah,  FL). 
10,000 cells were analyzed in each instance and all histograms are shown 
on a three-decade log scale. 
The average number of CD20 molecules present on the surface of paren- 
tal Daudi cells was estimated by determining the number of anti-B1  mAb 
binding sites by Scatchard analysis (39). Cells were incubated for 60 rain 
at 4°C with sub-saturating amounts of 125I-labeled anti-Bl mAb in PBS. 
The cells were then layered on a 750-#1 cushion of 75 % (vol/vol) calf serum 
and centrifuged. The cell pellet was isolated and bound 1251 assessed by 
gamma counting. The specific activity of labeled mAb was determined by 
self-displacement curve analysis (7).  The approximate number of CD20 
molecules present on the surface of  transfected cells was determined by flow 
cytometry analysis using Daudi cells as a standard. Cells were treated with 
saturating concentrations of FITC-conjugated anti-Bl mAb (Coulter Immu- 
nology, Hialeah, FL) and the mean channel of fluorescence staining deter- 
mined by flow cytometry analysis using a linear scale. Approximate values 
for numbers of CD20 molecules were determined by extrapolation from 
values obtained with Daudi ceils. 
Biochemical A nalysis 
Cells were washed twice, resuspended in saline, and surface labeled by 
lactoperoxidase-catalyzed iodination as described (18).  Alternatively, the 
ceils (107 cells/ml) were metabolically labeled by culturing them for 90 
rain in medium containing [32p]orthophosphate (125/~Ci/ml) after culture 
in phosphate-deficient medium for 60 rain as described (47). In some ex- 
periments, PMA (I00 ng/ml; Sigma Immunochemicals, St. Louis, MO) was 
added to the cultures during the last 15 rain of labeling. After labeling, the 
cells were washed twice and lysed in 1 nO of buffer containing 1% (vol/vol) 
Triton X-100 and protease inhibitors as described (47, 53). Immunoprecipi- 
tations were carried out using anti-Bla mAb and protein A-coated Sepha- 
rose beads (Pharmacia-LKB, Piscataway,  NJ).  The cell lysates were first 
precleared twice for 2 h using 2 #1 of ascites fluid containing an unreactive 
IgG2a mAb and 50 ~,1 (50%  vol/vol) protein A-Sepharose at 4°C.  The 
precleared lysate was then divided into equal samples and incubated with 
2 #1 of anti-Bla mAb and 50 ~1 of protein A beads (50% vol/vol) or murine 
IgG and beads with constant rotation at 4"C for 18 h. Immunoprecipitates 
were washed and analyzed by SDS-PAGE as described (47, 53) with subse- 
quent autoradiography. Relative molecular weights were determined using 
pre-stained standard molecular weight markers (GIBCO BRL). 
Chemical Cross-linking of  CeU Surface Molecules 
B  lymphoblastoid cells  (BJAB;  2  x  106/ml)  were  surface  labeled  by 
lactoperoxidase-catalyzed iodination, suspended in cold PBS (pH 7.0) and 
kept on ice. Dithiobis(succinimidylpropionate)  (DSP) l  (Pierce Chemical 
1. Abbreviations  used in this paper: CRAC, calcium release-activated cal- 
cium,  DSP,  dithiobis(succinimidylpropionate); NMDG,  N-methyl-o-glu- 
camine. 
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proteins. DSP was dissolved in DMSO (10 mg/ml) and added to the cell 
pellet at a final concentration of 10/~g in I ml. The cross-linking reaction 
was allowed to proceed for 50 rain while kept on ice to reduce the fluidity 
of the plasma membranes. After this treatment, the cells were washed twice 
with cold PBS and lysed in buffer containing 0.5% NP-40, and 1% (wt/vol) 
BSA as described (47).  CD20 was first precipitated from the detergent- 
solubilized material, followed by MHC class 1 antigen using W6/32 anti- 
body as described (47). BSA was included in excess in all lysis and wash 
buffers to prevent further cross-linking of the solubilized membrane pro- 
teins. Immunoprecipitated proteins were divided and electrophoresed  in the 
presence of SDS on a  10% acrylamide gel. One lane of the gel was fixed 
and dried for autoradiography. The other lane was soaked in an SDS solu- 
tion containing mercaptoethanol (5%) for 2 h, laid on top of another 10% 
acrylamide slab gel, electrophoresed under reducing conditions, and an- 
toradiographed. All autoradiographs were exposed for 5 d, except the MHC 
class I immunoprecipitations, which were only exposed overnight. 
Whole-CeU Patch-Clamp Analysis 
All transfected cells were cultured in RPMI  1640  with 10%  FBS added. 
All cells were kept at 37°C in 95%  CO: and the cell density was main- 
tained at  ,~106 cell/ml.  Immediately before use,  the cells were washed 
twice  in  serum-free RPMI  1640,  and  placed  in  a  perfusion chamber 
mounted on the stage of a Nikon diaphot inverted microscope. All dec- 
trophysiolngical experiments were performed at room temperature (24  5: 
2°C). 
High-resistance seals (10-100 Gohms) between micropipettes (0.5-1 mi- 
cron i.d.) and individual cell plasma membranes were formed as previously 
described (23). The whole-cell configuration was achieved by a sharp suc- 
tion pulse immediately after seal formation to rupture the plasma membrane 
within the seal. In this configuration, the soluble cytosolic contents are dia- 
lyzed by the pipette filling solution.  The pipette solution was  120  mM 
N-methyl-o-Glucamine (NMDG) glutamate, 5 mM Hepes, 1 mM EGTA, 
1/zM free Ca  2+, pH 7.0, for most experiments. The bath solution was 150 
mM NMDG glutamate, 5 mM Hepes, 1 mM EGTA, 1 mM free Ca  2+, and 
the pH was adjusted to 7.0 with either NaOH or HCI. Under these condi- 
tions, the principal membrane permeant ion was Ca  2+, and the only ionic 
gradient was the Ca  2+ because both pipette and bath solutions were made 
from the same pH adjusted stock solutions. The pipette solution was made 
hypotonic to prevent cell swelling after formation of the whole-cell configu- 
ration (59). Leak currents were determined for each cell using the current 
measured at the equilibrium potential for Ca  2+ (EcF+ =  +90 mV), where 
all of the current could only be leak. The ohmic conductance (linear slope) 
between EcF+ (where all of the current was leak),  and 0 mV (where, by 
definition, there can be no leak current) was used to determine the magni- 
tude of the leak current at each test potential, which was subsequently sub- 
tracted from all  records to yield uncontaminated Ca  2+ current.  Liquid 
junction potentials between the pipette and bath solutions were balanced im- 
mediately before giga-ohm seal formation. Capacitance and series resis- 
tance were compensated immediately after formation of the whole-cell 
configuration, and not altered for the duration of any single experiment, 
even though perfusion of the bath changed the height of the solution conse- 
quently altering the capacitive properties of the whole-cell preparations. 
The experimental conditions specified a theoretical membrane potential 
of +90  mV  (i.e.,  the  equilibrium  potential  for  Ca  z+  which  would  be 
achieved in a perfect system, with 0 leak). The actual membrane potential 
(measured by current clamping the cell to 0 current) was +60 mV, due to 
a small amount of leak permeability. Therefore, cells were held at +60 inV. 
Ca  2+ currents were elicited from test clamps to membrane potentials as 
negative as -100 mV, in 20 mV increments. No difference in steady state 
current was observed at 40 ms or at 750 ms after the initiation of the test 
clamps so all current-voltage relations were determined from the steady 
state currents (measured 40 ms after clamping to each test voltage) to avoid 
contamination from uncompensated capacitance (which subsided within 3 
ms after the test clamp was initiated). 
In some experiments, PMA (1 mg/ml in DMSO; Sigma Immunochemi- 
cais) was included in the bath solution at a final concentration of 1 #g/ml 
and 4  mM ATP was added to the pipette solution.  Cells were similarly 
treated with the PMA analog, 4ot-phorbol 12,13-didecanoate (Sigma Im- 
munochemicals),  or  appropriately  diluted  DMSO  without a  detectable 
effect on Ca  2+ conductance. 
Fura-2 Fluorescence Microscopy 
CD20  + and  CD20-  ceils were  incubated in  RPMI  1640  medium sup- 
plemented with 5 ~M fura-2/AM at 37°C for I h. Cells were washed twice, 
resuspended in fresh culture medium, and incubated for an additional h to 
dialyze away residual acetomethyl ester form of the dye (56). Dye-loaded 
cells were plated  in a  perfusion chamber mounted on the stage of an 
Olympus IMT2 inverted microscope fitted with a quartz light path to facili- 
tate 340 nM UV light.  Excitation wavelengths of 340 and 380 nM with 
2-nM bandwidths were generated with a dual excitation spectrophotometer 
(Photon Technologies, Inc., Princeton, NJ). The emission wavelength was 
510 nM. Single cells were isolated from the remainder of the field using 
a variable diaphragm. Photon counts were performed on individual cells 
using a microscope-adapted Leitz photometer system. The photon counting 
system and spectrophotometer were under computer control (IBM AT) 
using software from Photon Technologies, Inc. 
Measurements of cytosolic Ca  2+  were  obtained  on  individual  cells. 
Cell-free areas were measured to determine the background fluorescence. 
Experiments were only conducted when the cell/background fluorescence 
ratio exceeded 10:1. Measurements obtained at each wavelength were cor- 
rected for background before determination of the 340:380 ratio. Cytosolic 
Ca  2+ was calculated as previously described using in vitro determinations 
of the maximum and minimum ratios (21). 
Statistical A nalysis 
Statistical significance of results was determined using the paired t test. 
Results 
Expression of CD20 by cDNA-transfected Cell Lines 
Human eDNA encoding the entire translated  region of the 
CD20 gene was subcloned into a retrovirus vector and trans- 
fected into two human T lymphoblastoid cell lines (Jurkat 
and Rex), a murine pre-B lymphoblastoid cell line (300.19) 
(1), a human erythroleukemia cell line (K562) (27), and the 
murine NIH-3T3  fibroblast cell line.  In each case,  stable 
oligoclonal  cell lines that  expressed  CD20  were isolated, 
with the exception of Jurkat, which was clonal (Fig. 1). More 
than 95% of the cells from each line expressed CD20, as de- 
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l~gure  1.  CD20  expression by  cell lines transfected with  CD20 
eDNA. Cells were assessed for expression of CD20 by indirect im- 
munofluorescence staining with the anti-Bla mAb with subsequent 
flow  cytometry  analysis.  The  upper  left panel  histograms  show 
CD20 expression by Daudi lymphoblasts (  ) and an antibody 
control using unreactive mouse IgG antibody ( ..... ). The other his- 
tograms are of paired transfectant cell populations of 10,000 ceils 
each, showing plasma membrane expression of CD20 (~)  and 
lack of CD20  expression in vector-only transfected control ceils 
( .....  ). 
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specific mAb (anti-Bla) (43). Daudi cells endogenously ex- 
press an average of  60,000 CD20 molecules per cell, and the 
transfected cells expressed up to ~30,000 CD20 molecules 
per cell. The highest levels of expression were consistently 
observed with 3T3-CD20 cells >300.19-CD20 ceils  =  the 
Jurkat-CD20 clone >K562-CD20, with Rex-CD20 cells ex- 
pressing the least CD20 of all transfected cell lines gener- 
ated. The original phenotypes of the parent cell lines were 
preserved because the transfected cells expressed the same 
surface markers present in the parent lines.  Parental cells 
were also transfected with the retroviral vector lacking the 
CD20  cDNA  insert to  produce parallel  cell lines  which 
served as controls for subsequent physiological comparisons 
(Fig. 1). The establishment of  transfected cell lines which ex- 
pressed CD20, and their respective vector-transfected con- 
trois provided matched cells that differed by a single variable 
(i.e., expression of CD20) and were designated CD20  + and 
CD20-, respectively. 
Phosphorylation  of CD20 Expressed by 
cDNA-transfected Cells 
Since CD20 is a dominant phosphoprotein in B cell lines and 
phosphorylation may be a potential means of CD20 regula- 
tion, the ability of CD20 to serve as a  substrate for phos- 
phorylation in ectopic cell lines was examined to confirm 
that the transfected gene product retained the biochemical 
properties of endogenously expressed CD20.  CD20 immu- 
noprecipitated from [32p]orthophosphate-labeled cells dem- 
onstrated that CD20  was constitutively phosphorylated in 
transfected cells just  as  was  found in  normal B  lympho- 
blastoid cells (Daudi) (Fig. 2). Treatment of CD20  + trans- 
fectants with PMA also induced the same shift in Mr as oc- 
curs with CD20 endogenously expressed by B cell lines (Fig. 
2), confirming that activation of protein kinase C results in 
increased phosphorylation of transfected CD20 (53). These 
Figure 2.  Endogenous phosphorylation of CD20 and changes in 
phosphorylation following activation of protein kinase C. CD20 
was immunoprecipitated from Dandi cells and CD20 cDNA-trans- 
letted ceil lines cultured with [32p]orthophosphate  and analyzed 
by SDS-PAGE  with subsequent autoradiography. CD20 was consti- 
tutively phosphorylated to some degree in all cell types and treat- 
ment of the cells with PMA shifted the relative proportion of la- 
beled CD20 from the M, 33,000 form to the 35,000-37,000-Mr 
forms. Vector-transfected  Rex cells do not express CD20 and were 
included as a negative control. 
findings also demonstrate that the different relative molecu- 
lar weight species of CD20 result from the differential post- 
translational processing of a common protein because trans- 
fected ceils express multiple CD20 species that are identical 
to those found in B lymphoblastoid cells (47,  53). 
The extent of CD20 phosphorylation in transfected cells 
was consistently less than in CD20  + B lymphoblastoid cell 
lines. One explanation for this finding is that phosphoryla- 
tion of CD20 in exogenous cell types might be less efficient. 
Alternatively, the transformations responsible for producing 
malignant B lymphoblastoid cells may enhance the expres- 
sion or activity of specific kinases or phosphatases in B cell 
lines, resulting in hyperphosphorylation of CD20. 
CD20  +  Jurkat Cells Express Nascent Transmembrane 
Ca  2÷ Currents 
Whole-ceU patch-clamp (23) was used to measure plasma 
membrane ion currents in CD20  + and CD20- Jurkat trans- 
fectants to determine whether expression of CD20 could al- 
ter transmembrane Ca  2+ movement. When Jurkat cells were 
bathed in culture medium, ionic currents were observed in 
response to  vokage pulses  (100  to  ÷100  mV  in  20  mV 
increments  from a  holding potential of 0  mV)  in  CD20  + 
cells which were absent in CD20- cells (Fig. 3, A and B), 
indicating  that  the expression of CD20  increased plasma 
membrane  ionic  conductance.  The  inward  currents  in 
CD20  +  cells  were  eliminated  when  the  bath  Ca  2÷  was 
chelated to a  calculated final concentration of 6  nM with 
EGTA. Perfusion of the bath solution with Ba  2÷ increased 
the magnitude of the currents.  Subsequent perfusion with 
EGTA-supplemented culture  medium  eliminated  the  cur- 
rents, thereby confirming that Ba  2+ was the charge carrier 
and  that  Ba  2+  perfusion  specifically  altered  the  plasma 
membrane  conductance.  This  is  not  surprising  as  Ca  2+ 
channels typically conduct Ba  2÷ to  a  greater degree than 
Ca  2+ (22). The exponential decays in the transient currents 
when Ca  2÷ and Ba  2÷ were the charge carriers was examined. 
The time constant of current decay to steady state was 0.42 
ms  when Ca  2+ was the charge carrier and 0.46 ms  when 
Ba  2+ was the charge carrier. The similarity in the rate of de- 
cay  of the  transient  current  indicates  that  the  channels 
through which the current passed were unaffected by the 
different charge carriers. Therefore, the increased peak tran- 
sient current in the presence of Ba  2+ may simply reflect the 
relative ease with which Ba  2÷ flows through open CD20- 
associated  channels.  These  findings  indicate  that  the  in- 
creased current induced by ectopic expression of CD20 was 
carried specifically by Ca  2+.  However, contributions from 
Na  + or C1- to the inward current in CD20  + ceils could not 
be  completely excluded because the electrochemical gra- 
dients for these ions are appropriately oriented. 
To specifically examine transmembrane Ca  2+ currents in 
the transfected Jurkat cells,  all other permeant ions were 
eliminated  from the  bath  and  pipette  solutions  by  using 
NMDG glutamate bath  solutions.  NMDG  + is  an organic 
cation that is impermeant to the membrane, and likewise, 
glutamate-  is  also  an  impermeant  organic  anion.  Since 
these ions can not carry current across the plasma mem- 
brane,  they do not contribute to the membrane potential. 
Ca  2+ served as the only ion carrier in the bath solution (1 
mM free Ca  2+) and the pipette solution was buffered to  1 
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Figure 3. CD20-associated in- 
ward whole-cell currents from 
transfected  Jurkat  lympho- 
blasts.  The bath solution con- 
tained a 1:1 mixture of DME/ 
FI2 culture medium (free Ca  2+ 
= 0.4 raM), the same medium 
supplemented  with  5  mM 
EGTA (free Ca  2+ =  6 nM) or 
2  mM Ba  2+ as indicated.  All 
experiments  were  performed 
at  24  +  2°C.  The  currents 
shown in A and B were elicit- 
ed to hyperpolarizing voltage 
clamps to a membrane poten- 
tial  of -100 mV from a hold- 
ing  potential  of 0  mV.  (A) 
Three currents obtained from 
the same CD20  + clone.  Cur- 
rent b was recorded when the 
bath contained unsupplement- 
ed culture medium. Perfusion 
with EGTA-supplemented  culture eliminated  the Ca  2+ and the current (current a).  Perfusion with Ba2*-supplemented  (2 mM) culture 
medium increased the current (current c). All effects on the current were reversible.  (B) Typical currents  (a, b, and c as described above) 
from a single CD20-transfected Jurkat clone, showing that the control (CD20-) transfectants  did not express the current observed in the 
CD20  + transfectants.  (C) Whole-cell Ca  2+ currents from CD20  +- and CD20-- transfected  Jurkat lymphoblasts generated in response to 
hyperpolarizations to -100 mV from a holding potential  of +60 mV. The dashed line indicates  the 0 current level.  Ca  2+ was the only 
membrane-permeant ion in the pipette  and bath solutions,  which contained NMDG-glutamate. The smaller current typifies the currents 
observed in CD20- cells.  The larger current typifies  the currents observed in CD20  + cells.  The arrow indicates  the point at which all 
steady state  currents were measured (40 ms after initiation  of the test clamp). 
#M free Ca  2+ with EGTA. Therefore,  the theoretical equi- 
librium  potential  (Ec,~+) across the plasma membrane  was 
÷90  mV.  Under  current  clamp  (to  0  current)  the  actual 
membrane potential was consistently measured at approxi- 
mately +60 mV,  close to the Ec,2+, indicating that the pre- 
dominant conductance was Ca  2÷ with a relatively small leak 
conductance.  Whole-cell  voltage  clamps  (ranging  from 
-100 mV to +100 mV in 20 mV increments) from a holding 
potential of +60 mV induced whole-cell currents in CD20  + 
transfectants (Fig. 3  C) which were qualitatively similar to 
those elicited  when the bath  solution was culture medium 
(Fig,  3 A). 
CD20+-transfected Cells Show Enhanced 
Ca  2÷ Conductance 
Whole-cell patch clamp recording was also used to examine 
the Ca  2+ conductance in Daudi B  lymphoblasts (which en- 
dogenously express  CD20)  and  of four types of cells  (of 
unrelated  origin)  that  were transfected  with  CD20.  Daudi 
cells  had  a  voltage-insensitive,  inwardly  rectified  steady- 
state Ca  2+ conductance of 660  5:185 pS/20 pF (Fig. 4 A). 
Conductances were calculated as chords conductance from 
a  test potential of -80  mV.  Comparisons of ionic conduc- 
tance between  matched  pairs of CD20  + and CD20- trans- 
fectants were used to determine whether expression of CD20 
altered  Ca  2+ conductance specifically,  and  for comparison 
with the Ca  2+ conductance of cells which endogenously ex- 
press  CD20.  The  qualitative  and  quantitative  findings  of 
whole-cell patch clamps on CD20-transfected cells and their 
respective controls indicate that in four of the cell types Our- 
kat,  300.19,  K562,  and NIH-3T3) expression of CD20 in- 
creased plasma membrane Ca  2+ conductance (Fig. 4, B-F). 
Further,  the Ca  2+ conductances of CD20  + cells were quali- 
tatively  similar  to the Ca  2+ conductance of Daudi B  lym- 
phoblasts.  The current-voltage relations  indicated that the 
Ca  2+ conductance was not voltage dependent,  but the cur- 
rents were inwardly rectified at hyperpolarizing membrane 
potentials  (-80 mV and -100 mV).  These findings indicate 
that expression of CD20 endows a variety of cells of different 
lineages with the same Ca  2+ conductance that is present in 
cells  which  endogenously express  CD20.  The  fifth  trans- 
fected  cell  type  (Rex)  showed  no  significant  increase  in 
Ca  :+ conductance between  CD20  + cells  and  CD20-  cells 
(Fig.  4C).  However,  Rex-CD20  cells  expressed  approxi- 
mately five times less CD20 than the other transfected cell 
lines  (Fig.  1).  The mean  Ca  2÷ conductance in each of the 
cell types correlated well with the average amount of CD20 
expressed by each cell type (r =  0.814) suggesting that Rex- 
CD20 cells did  not express  enough CD20 to increase  the 
plasma  membrane  Ca  2+ conductance  to detectable  levels. 
Therefore,  the  most  likely  explanation  for  the  increased 
Ca  2+ conductance associated with CD20 expression is that 
CD20 itself is a  Ca  2+ channel. 
CD20 Expression Alters Cytosolic-free Ca  t+ Activity 
Since membrane expression of CD20 correlated with an in- 
crease in transmembrane Ca  2+ conductance, changes in in- 
tracellular  free  Ca  2+  concentration  were  also  examined. 
CD20  + and  CD20- Jurkat  transfectants  were  loaded  with 
the  Ca2+-sensitive  fluorophore,  fura-2.  The cells  were ex- 
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Figure 4. Leak-subtracted  steady-state current-voltage  relations for cells expressing CD20. (,4) Daudi lymphoblasts,  which constitutively 
express  CD20,  typically had an inward rectified voltage-insensitive  Ca  2÷ conductance. (B) CD20  ~ and CD20- transfected/urkat cells. 
The expression of CD20 added a voltage-insensitive,  inward rectified component to the whole-cell Ca  2÷ current. (C) Typically Rex cells 
had little Ca  ~÷ conductance (75 % of the cells), and the expression of CD20 did not significantly increase the conductance. However, Rex 
cells expressed very little CD20 compared to Daudi cells or any of the four other transfected cell lines. Therefore the lack of a significant 
CD20-associated  current in Rex cells was most likely due to the low levels of CD20 expression.  (D) CD20  + and CD20- mouse 300.19 
pre-B cells. The effect of CD20 on the Ca  2÷ current in these cells was identical to the effect observed in transfected Jurkat cells. (E) The 
current-voltage relations from CD20- and CD20  + K562 erythroleukemia ceils show the typical increase in inward rectified voltage-insen- 
sitive Ca  2÷ conductance associated with the expression of CD20. (F) Expression of CD20 by NIH-3T3 fibroblasts induced a greater than 
fourfold increase in Ca  2÷ conductance (238  +  95 pS, n  =  5 for CD20- cells; 955  ±  39, n  =  4 for CD20  ÷ cells) which was qualitatively 
similar to the non-voltage-dependent  inward rectified Ca  2÷ conductance associated with CD20 in Daudi cells and each of the transfected 
cell lines. 
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Figure 5. Fura-2 fluorescence 
measurements  of  cytosolic- 
free Ca  2+ activity in CD20  +- 
and CD20--transfected Jurkat 
lymphoblasts. The horizontal 
bar  indicates  the  perfusion 
protocol and the results shown 
are from representative single 
cells. Increasing the extracel- 
lular Ca  2+ concentration from 
50 nM to 400/~M  induced a 
large  intraceUular free Ca  2+ 
activity  increase  in  CD20  + 
cells and only a small increase 
in CD20- cells, directly dem- 
onstrating  that expression of 
CD20 increased plasma mem- 
brane Ca  2+ permeability. These 
results  are  representative  of 
those obtained in four separate 
experiments. 
amined by dual-excitation, single-emission fluorescence mi- 
croscopy and compared to determine whether the expression 
of CD20  altered  the  steady-state  cytosolic Ca  ~+  activity. 
CD20  + cells had a significantly higher cytosolic Ca  2+ activ- 
ity than  CD20-  cells  (124  +  47  nM,  n  =  20  in CD20  + 
cells, vs. 58 d- 45 nM, n  --- 20, in CD20- cells: P <  0.001). 
Fura-2-1oaded  cells  were  preincubated  in  Ca2+-depleted 
culture medium (5 mM EGTA added) and then re-exposed to 
extracellular Ca  2+ (400 #M) by perfusion with normal cul- 
ture  medium.  CD20  + transfectants  had  a  sixfotd greater 
rate  of increase  in  intracellular  free Ca  2+  activity  in  re- 
sponse  to  re-exposure to  Ca  2+,  compared  to  the  CD20- 
controls (Fig. 5). This observation is consistent with the hy- 
pothesis that CD20 expression increases plasma membrane 
Ca  2+ permeability, which accordingly accounts for the in- 
creased steady state cytosolic Ca  2+ activity. 
mAb Binding to CD20 Increases Ca  2+ Conductance 
The binding of the anti-Bla mAb to CD20 on B lymphocytes 
alters cell cycle progression of mitogen-activated B lympho- 
cytes suggesting that it dysregulates a required process (51). 
However, treatment of B lymphoblastoid cell lines with the 
anti-Bla mAb does not affect the growth of  transformed cells. 
Therefore, Daudi B lymphoblastoid cells were used to deter- 
mine whether mAb binding to CD20 could affect Ca  2+ con- 
ductance. The Ca  ~÷ current in Daudi cells was not acutely 
altered by their exposure to saturating concentrations of the 
CD20-specific anti-Bla mAb (25 #g/ml for up to  15 min). 
However, in a paired comparison, Daudi cells incubated with 
anti-Bla rnAb (25 #g/ml) for 24 h had a steady-state inward 
conductance of  976 +  341 pS/20 PF (n =  3) at hyperpolariz- 
ing clamp steps, compared to 424  +  82 pS/20 pF (n  =  6) 
in cells not exposed to the CD20 mAb (P < 0.05). This effect 
appeared specific for CD20 because similar changes were 
not observed in cells treated with an isotype-matched mAb, 
HB-5,  that binds to cell-surface CD21  on B  cells.  These 
results indicate that binding of  the anti-Bla mAb to CD20 did 
not cause acute alterations in Ca  :÷ currents.  However, the 
findings clearly demonstrate that chronic treatment alters 
Ca  2+  homeostasis  which  could  account  for  the  mAb- 
induced effects on B lymphoblast cell growth/cell cycle. 
Previous studies failed to detect significant changes in in- 
tracellular  free  Ca  ~+  activity  immediately  after  anti-Bla 
mAb binding to CD20 on spleen B lymphocytes (51). How- 
ever, the effects of long-term exposure to the mAb on cyto- 
solic Ca  2. have not been previously examined.  Therefore, 
the effects on cytosolic Ca  2+ activity resulting from anti-Bla 
mAb  binding  to CD20  for 24  h  were examined in  fura- 
2-loaded Daudi  cells.  As  previously described,  culturing 
cells with the anti-B1 (CD20) mAb resulted in redistribution 
of the  surface  antigen  into  patches,  but  did  not  down- 
modulate surface expression or appear to result in receptor 
internalization (31, 51). Cells cultured without anti-Bla mAb 
present had an average steady-state cytosolic Ca  2+ activity 
of 46  +  15 nM (n  =  30). Incubation of the cells for 24 h 
with  saturating  amounts  of the  anti-Bla mAb  (25  #g/ml) 
significantly increased the cytosolic Ca  2+ activity to 123  + 
80 nM (n =  30; P < 0.001). These results are consistent with 
the electrophysiological observations that 24 h was required 
for  anti-B1  mAb  binding  to  increase  plasma  membrane 
Ca  2+ conductance. 
In contrast to the anti-Bla mAb, binding of the 1F5 mAb, 
which recognizes a CD20 epitope that is different from the 
epitope  bound  by  the  anti-Bla  mAb  (48),  causes  acute 
changes in activation/signal transduction of normal B cells 
(10, 40). Consistent with this, exposure of Daudi cells to the 
1F5 mAb (25/zg/ml), acutely increased Daudi cell whole- 
cell Ca  2+ current (within 1 rain) (Fig. 6). Thus, mAb bind- 
ing of 1F5 to the CD20 molecule appears to directly alter 
Ca  2+  current.  These  direct  electrophysiological observa- 
tions  confirm that  mAb  binding  to  different epitopes  on 
CD20 can induce either acute or delayed changes in Ca  2+ 
current. It was also observed that 1F5 rnAb treatment had no 
net  acute  effect on  the  cytosolic  Ca  2+  activity  in  Fura- 
2-loaded Daudi  cells consistent with  earlier publications 
(20).  Therefore, because of Ca  2+ buffering activity within 
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Figure 6. The effect of IF5 mAb binding to CD20 on whole-cell 
Ca  2+ current in Daudi lymphoblasts. (.4) Whole-ceil Ca  2+ currents 
generated in response to test voltages of -100 mV to +100 mV in 
20 mV increments from a holding potential of+60 mV. (B) Whole- 
cell Ca  2+ currents from the same cell described in A, 1 rain after 
exposure to CD20-specific mAb (1F5; 25/~g/ml). Capacitance was 
compensated  immediately after the whole-cell configuration was 
formed and was not reeompensated during the course of the various 
perfusions,  because  this  compensation  could  artifactually  alter 
whole-cell currents. (C) Steady state current-voltage relations be- 
fore and after 1F5 mAb exposure measured at 45 ms. Values repre- 
sent the average current-voltage relations (+SEM) obtained in six 
experiments. 
cytoplasm, the voltage clamp finding may not directly reflect 
the total effect of 1F5 on in vivo Ca  2+ homeostasis. 
Binding of mAb to CD20 Alters Cell Cycle-dependent 
Changes in Cytosolic Ca  z+ Activity 
Binding  of the  anti-Bla  mAb  to  normal  B  lymphocytes 
blocks the transition of cells from the G1 phase of cell cycle 
into  the  S-G2/M  phases,  but  does  not  alter  cell-cycle 
progression  in  transformed  B  lymphoblastoid cells  (51). 
Similarly,  changes in  intracellular  free Ca  2+  activity also 
accompany cell  cycle progression  with  G,  phase B  lym- 
phoblastoid cells having higher levels of intraceUular free 
Ca  :+  activity  that  returns  to  lower  levels  with  cell  cycle 
progression (Bubien, J.  K., and P.  D. Bell,  manuscript in 
preparation). Therefore, to determine whether mAb binding 
to CD20 alters the normal changes in cytosolic Ca  :+ activ- 
ity that occur with cell cycle progression, Daudi cells were 
suspended at the G1-S stage of ceil cycle by treatment with 
hydroxyurea (1 mM for 24 h). The mean free cytosolic Ca  :+ 
activity was 42  5:14 nM (n  =  10) in these cells, whereas 
the cytosolic Ca  :+ activity of cells from the same popula- 
tion  24  h  after  release  from  hydroxyurea  block  was 
significantly lower (27  5-  3  nM,  n  =  10;  P  =  0.002).  In 
paired trials, the cytosolic Ca  2+ activity of G1-S phase ceils 
also cultured with the anti-Bla rnAb was the same as the con- 
trol hydroxyurea-treated cells. However, the mean cytosolic 
Ca  :+ activity of cells that were released from hydroxyurea 
for 24 h in the presence of the anti-Bla mAb was 55  5- 25 
nM (n =  10). These results directly demonstrate that binding 
of the anti-Bla mAb to CD20 prevented a decrease in cyto- 
solic free Ca  2+ activity as the ceils progressed beyond G~-S 
of the cell cycle, as was observed in the control cells. Thus, 
one potential mechanism whereby mAb binding to CD20 
may disrupt normal cell-cycle progression could be by al- 
tering CD20-associated cell cycle-dependent Ca  e÷ homeo- 
stasis. 
PMA Treatment Reduces CD20 Associated 
Ca  z+ Conductance 
Daudi  cells  were  whole-cell  clamped  as  previously  de- 
scribed with NMDG-glutamate bath and pipette solutions. 
The Ca  2+ concentration of the bath solution was 1 mM and 
1/~M in the pipette solution with all voltage clamp and leak 
subtraction protocols used as previously described. After as- 
sessing the control CD20-associated Ca  2+ conductance, the 
cells were perfused with a bath solution supplemented with 
1/tM PMA and the whole-cell CD20--associated Ca  2+ con- 
ductance was assessed by voltage clamp at 1 min (Fig. 7). 
PMA  treatment  reduced  the  whole-cell  CD20-associated 
Ca  2+ conductance from 520  +  125 pS/20 pF to 406  5:111 
pS/20 pF after 1 rnin.  A reduction in the conductance was 
observed in eight out of nine cells, and one cell had a very 
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Figure 7. The effect of PMA treatment on CD20-associated  Ca  2+ 
current in Daudi cells. Values represent the mean current-voltage 
relations (+SEM) obtained  in paired experiments in eight out of 
nine cells tested.  Control  values represent untreated cells, while 
PMA (1/~M) treatment decreased the currents 1 rain after exposure. 
In control experiments where cells were treated with a 4ct-phorbol 
ester analogue (1 #M) or carrier solution (diluted DMSO) the cur- 
rent-voltage relations of paired cells were unaffected. 
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duced to 330 pS/20 pF after PMA treatment. The difference 
in conductance (113 +  37 ps/20 pF, n  =  7) was significant 
(P =  0.023)  after these two outlying cells were eliminated 
from the pool. Although PMA was used at 1/tM because of 
the acute nature of the experiments and that a functional con- 
centration of PMA had to cross the plasma membrane in a 
relatively short time, no difference in conductance was ob- 
served in control experiments using the 4-tx phorbol ana- 
logue,  that  does  not activate protein  kinase C  (data  not 
shown). This finding implies that protein kinase C-mediated 
phosphorylation of CD20 inactivates CD20-associated Ca  2+ 
current, and this may be one molecular mechanism for regu- 
lation of transmembrane Ca  2+ conductance in B  lympho- 
cytes. 
In Situ Oligomeric Structure of CD20 
Immunoprecipitation studies have previously demonstrated 
that CD20 associates with other cell surface and eytosolic 
proteins (47, 53). The possibility that CD20 residues in the 
plasma membrane as a multimolecular complex was inves- 
tigated  by  biochemically crosslinking  plasma  membrane 
proteins followed by specific immunoprecipitation of CD20 
and spatially close (i.e., cross-linked) proteins. Radiolabeled 
membrane proteins of the B lymphoblastoid cell line, B  JAB, 
Figure 8. In situ chemical cross-linking of cell-surface molecules 
with subsequent immunoprecipitation of CD20. (,4) Three domi- 
nant protein bands (33,000, 70,000, and 140,000 Mr, indicated by 
arrowheads) were immunoprecipitated from surface-iodinated B 
lymphoblastoid cells (B  JAB) with the anti-Bla mAb after  DSP 
cross-linking  of  plasma membrane proteins. Gel analysis of  the im- 
munoprecipitated materials was run under non-reducing condi- 
tions. The control lanes represent materials precipitated by an iso- 
type-matched unreacfive mAb. MHC class I antigens were also 
immunoprecipitated from the same cell lysate revealing only a 
single monomeric molecular species. (B) Two-dimensional  anal- 
ysis of the materials isolated in A. Proteins electrophoresed in the 
first dimension were treated with reducing conditions (to break the 
disulfide bond of the cross-linking agent) and run in the second 
dimension under reducing conditions. Each of the bands identified 
under non-reducing conditions migrated at 33,000 Mr, indicating 
that the larger bands were comprised of  CD20 monomeric subunits. 
The relative molecular weight of proteins with known molecular 
weights are indicated (kD). 
were covalently cross-linked with DSE on ice, to maintain 
the association of all proteins with exposed proximal pri- 
mary amino groups within up to 12 A of  each other. The cells 
were then washed and lysed with detergent in the presence 
of 1% (wt/vol) BSA. Immunoprecipitation of  CD20 from the 
cross-linked  membrane  proteins  revealed  three  distinct 
bands  33,000--35,000,  70,000,  and  140,000  Mr (Fig.  8 A, 
arrowheads).  A  cell-surface protein  of '~31,000  Mr  that 
specifically coprecipitates with CD20 was also observed be- 
low the 33,000 Mr CD20 band as previously described (35, 
53).  The disulfide bond of DSP was subsequently reduced 
to dissociate the cross-linked proteins and the PAGE gel was 
again run in a second dimension. After dissociation and elec- 
trophoresis, the 70,000 and 140,000 Mr bands migrated to 
form bands at 33,000-35,000 Mr (Fig. 8 B), suggesting that 
the larger bands represented homodimeric and homotetra- 
merit  oligomers  of CD20.  The  band  at  31,000  Mr  that 
coprecipitates with CD20 was also visualized. All reactions 
were carried out in the presence of excess unlabeled protein 
to insure that the multimeric forms of CD20 were obtained 
exclusively from  the  crosslinked  membrane  proteins.  In 
similar experiments carried out with [32p]orthophosphate- 
labeled cross-linked cells, each of the bands comprising the 
monomeric  and  multimeric  forms  of CD20  were  phos- 
phorylated (data not shown). Immunoprecipitation of MHC 
class I antigens from the same lysate of cross-linked cells re- 
vealed that class I molecules were not cross-linked, thereby 
indicating that cross-linking of CD20 was specific and that 
not all cell surface molecules were chemically coupled. 
Discussion 
In this report, four complimentary experimental results are 
presented, each of which indicate that CD20 plays a direct 
role  in  regulating  plasma  membrane  Ca  2+  permeability. 
First, CD20 cDNA-transfected Jurkat T lymphoblasts, mu- 
rine 300.19 pre-B lymphoblasts, K562 human erythroleuke- 
mia cells, and NIH-3T3 murine fibroblasts all acquired a 
qualitatively similar Ca  2÷ conductance not present in their 
respective  CD20-  controls  (Fig.  3  and  4).  The  CD20- 
associated Ca  2+ currents observed in the transfected cells 
were  identical to  Ca  2+  currents  observed  in  Daudi  lym- 
phoblasts which endogenously express  CD20.  They were 
also similar to Ca  2÷ currents observed in MHY206 cells (4) 
and S194 cells (16), both of  which are murine B lineage cells, 
and  therefore,  presumably  endogenously  express  CD20 
(52). Second, the rate of Ca  2+ influx into Ca2+-depleted Jur- 
kat  cells  in  response  to  Ca  2÷  reperfusion  was  six  times 
higher in CD20  ÷ transfectants than matched controls (Fig. 
5).  Third,  expression of CD20  increased the steady-state 
cytosolic Ca  2+ activity in transfected Jurkat cells,  an ex- 
pected consequence of enhanced plasma  membrane  Ca  2+ 
permeability.  Finally,  mAb  binding  to  CD20  increased 
whole-cell Ca  ~+ currents in B lymphoblastoid cells (Fig. 6). 
Taken together, these results provide evidence that CD20 is 
itself a Ca  2+ channel or directly regulates Ca  2+ channel ac- 
tivity. 
Chemical cross-linking of plasma membrane proteins fol- 
lowed by immtmoprecipitation of CD20 revealed that CD20 
formed oligomeric complexes in the plasma membrane com- 
posed of two and four homologous subunits (Fig. 8). There- 
by, CD20 structure and oligomeric complex formation are 
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characterized ion channels. The rat brain Na  + channel sub- 
components possess four membrane-spanning domains and 
the channel complex is composed of four repeating homo- 
logous subunits (45).  Similarly, the GABA^ receptor Cl- 
channel is composed of five repeating homologous subunits, 
and  each  subunit has  four  membrane-spanning  domains 
(36).  These properties are also found with the family of 
glutamate receptor ion channels, which characteristically 
have four membrane spanning domains and form homomeric 
and heteromeric channels (41). The acetylcholine receptor 
subunits also have four membrane spanning domains, but 
four different subunits assemble into a heteromeric complex 
of five subunits forming an uncharged channel (12).  Thus, 
the finding that CD20 forms homo-oligomers in the plasma 
membrane suggests that a  multimeric form of CD20 may 
constitute the functional configuration of the protein. 
Three possible models of how CD20 regulates transmem- 
brane Ca  2+ current are possible. First, CD20 may not itself 
be a component of a Ca  2+ channel, but mAb or ligand bind- 
ing to the CD20  complex may initiate second messenger 
pathways that regulate transmembrane Ca  2+ current through 
endogenous channels.  However,  in  the  whole-cell clamp 
configuration the cytoplasmic contents are dialyzed out of 
the cell suggesting that cytosolic second messengers such as 
ATE  cAMP,  NO,  cGMP,  and  Ca  2+  would be  removed. 
While other components such as diacylglycerol, protein ki- 
nase C, and protein kinase A would remain within the mem- 
brane, signal generation may be inefficient at best. Second, 
CD20 may be in intimate physical association with a Ca  2+ 
channel forming complex and thereby transmit signals di- 
rectly to the complex to regulate Ca  2+ flux. The third pos- 
sibility is that the CD20 complex itself is the ion channel. 
The third possibility is best supported by the data as endoge- 
nous Ca  2+ channel activity similar to that found in B lym- 
phoblastoid cells was not found in T lymphoblasts, erythro- 
leukemia cells or fibroblasts, arguing against the presence of 
a similar channel endogenous to these disparate cell types 
that was only detected when CD20 was present. Further- 
more,  since the expression of CD20  in heterologous cell 
types generated a  qualitatively similar channel activity to 
that found endogenously in B lymphocytes, it is likely that 
it at least forms an essential component of  a channel complex 
expressed by B lymphocytes. Furthermore, the strategy of 
ectopic expression of eDNA resulting in the generation of 
nascent channel activity or reconstimfion of channel activity 
has been used repeatedly to verify the isolation of eDNA en- 
coding ion channels or their subunits (29,  30, 34, 36, 46). 
These experiments do not unambiguously prove whether 
or not CD20 itself is a Ca  2+ channel. Unfortunately, at the 
present time there is no single experiment or set of experi- 
ments which can answer this question. While isolation of 
pure  CD20  and incorporation of CD20  into planar lipid 
bilayers could be a means of directly addressing this ques- 
tion, this requires the biochemical purification of CD20 to 
homogeneity. A purification protocol without use of CD20- 
specific mAb has not yet been successfully developed as con- 
ditions which remove the CD20 protein from the CD20 mAb 
appear to denature CD20 structure. In addition, polypep- 
tides not thought to have membrane-spanning regions such 
as the first nucleotide binding domain of cystic fbrosis trans- 
membrane regulator protein can form ion-conductive pores 
in planar lipid brayers (2), casting doubt on the perception 
that re,  constitution of a protein into planar lipid bilayers and 
the  subsequent  measurement of an  ionic  conductance is 
definitive. Further, such experiments provide no assurance 
that the tertiary or quaternary structure of the isolated pro- 
tein is preserved during the isolation procedure or that neces- 
sary cellular components that regulate channel function are 
co-purified. Given all of these constraints, it is possible that 
such experiments may be less definitive  than the paired trans- 
fectant experiments presented in this study where CD20 was 
expressed by ectopic cell types and a similar nascent channel 
activity was detected in all cells expressing high levels of 
CD20. 
Since  CD20  itself appears  to  directly mediate plasma 
membrane Ca  2+ conductance in B lymphocytes, it follows 
that regulation of CD20 can provide a means by which B 
lymphocytes are  able  to  control plasma  membrane Ca  2+ 
influx. Phosphorylation may be one molecular mechanism 
used by B lineage cells to regulate CD20 function. CD20 ex- 
pressed by transfected cells was constitutively phosphory- 
lated to some extent and PMA-induced activation of protein 
ldnase C increased the extent of phosphorylation thereby in- 
creasing the apparent molecular weight of  the ectopic protein 
(Fig. 2) as occurs with endogenously expressed CD20 (47). 
Many ion channel proteins are phosphorylated, and their 
functions are presumably affected by the degree to which 
they are phosphorylated and the site of  phosphorylation. The 
Na  + channel, the acetylcholine nicotinic receptor K  + chan- 
nel,  and the  dihydropyridine-sensitive Ca  2÷  channel  pro- 
teins are all phosphorylated by both cyclic AMP-dependent 
protein kinase and protein ldnase C (30).  Phosphorylation 
directly alters the open probability of the dihydropyridine- 
sensitive Ca  2+ channel (14). Similarly, the function of CD20 
may be directly modified by phosphorylation. In the present 
study, PMA treatment significantly reduced CD20-associ- 
ated Ca  2+ conductance (Fig. 7). However,  it is possible that 
phosphorylation of CD20 on other residues by other kinases 
may have positive effects on CD20 function. Alternatively, 
phosphorylation of CD20 may be only one component of a 
more complex regulatory mechanism such as oligomer as- 
sociation or dissociation. For example, an oligomeric chan- 
nel complex may be formed from a pool of  monomeric CD20 
as the monomers become phosphorylated or dephosphory- 
lated. Phosphorylation-mediated regulation of CD20 func- 
tion could also be a dynamic process involving multiple ki- 
nases  that  are  differentially activated  during  cell  cycle 
progression. 
Whole-cell Ca  2+ currents remarkably similar to CD20- 
associated currents have been observed in mast cells and 
termed Ic~c (calcium release-activated calcium) (24).  The 
C#  + currents observed in mast cells are inwardly rectified, 
tend to partially inactivate with time, and are about 50-100 
pA when the cells are hyperpolarized to  -100 mV. CD20- 
associated Ca  2+ currents had identical characteristics. One 
apparent difference between the Ic~c currents and CD20- 
associated currents is the ability of Ba  2+ to carry the cur- 
rent. In the case of CD20-associated current, Ba  2+ appears 
to carry the current at least as well as Ca  2+ (Fig. 3), while 
in mast cells, B#  + appears to inhibit the Ic~c current. The 
striking similarity between the CD20-associated Ca  2+ cur- 
rents in B lymphocytes and the Ic~c C#  + currents observed 
in mast cells suggests that similar proteins may account for 
The Journal of Cell Biology, Volume 121,  1993  1130 these currents. Since mast cells express the F,RI/3 chain, 
which has amino acid sequence homology and a  similar 
hydropathy profile to CD20, it is possible that CD20 and the 
F,  RI/3 chain could have similar functional properties. 
CD20 expressed by B lineage cells associates with other 
plasma membrane proteins, providing a possible mechanism 
for the normal regulation of CD20 function. Immunoprecip- 
itation studies show that CD20 associates with a cell-surface 
protein of 29,000-31,000 Mr (Fig. 8), four cytoplasmic pro- 
teins in the relative molecular weight range of 50,000--60,000 
and  variably  with  a  large  cell  surface protein  (180,000- 
200,000 Mr) in B lymphoblasts (35, 53). However, transfec- 
tion of CD20 alone appears to be sufficient for the induction 
of Ca  2+ conductance in non-B lineage cells, because none 
of these proteins were detected in immunoprecipitations of 
CD20 in transfected T lymphoblasts (data not shown). This 
would suggest that coexpression of these proteins is not re- 
quired  to  reconstitute the  CD20-associated  Ca  2÷  conduc- 
tance. However, these findings do not rule out the possibility 
that accessory proteins play a role in regulating CD20 func- 
tion and that other endogenous regulatory molecules present 
in all cell types can affect CD20 activity. Accessory proteins 
present in the channel complex are important for the regula- 
tion of rat brain Na  + channels (34) and the dyhydropyridine- 
sensitive Ca  2+ channel (46).  These channels are composed 
of homologous and heterologous subunits.  However,  only 
single  subunit types are  required  to  reconstitute channel 
function in ectopic expression systems. The other subunits 
appear to only be necessary for regulation of channel func- 
tion (29).  This may explain why the CD20-associated Ca  2+ 
conductance was always found in an active configuration. 
Since, CD20 is related to the F,  RI/3 chain, it is possible 
that, as with the F,RI complex, additional ligand-binding 
components that associate with CD20 will be identified. 
Cytosolic Ca  2+ and cation channel activity vary with the 
cell cycle in lymphocytes, with cytosolic Ca  2+ being low in 
Go and S and increased threefold in Gi (5,  6).  Therefore, 
the finding that CD20 mediates or regulates a  transmem- 
brane Ca  2÷ conductance could provide a mechanistic expla- 
nation for the different biological effects of two CD20 mAb, 
1F5 and anti-Bla, which are both monospecific for CD20. 
Binding of the IF5 mAb to CD20 activates resting tonsillar 
B lymphocytes (10); while binding of the anti-Bla mAb has 
no effect on resting cells (50).  The binding of each mAb to 
CD20  blocks  cell cycle progression of mitogen-activated 
blood B cells (50). The voltage-clamp studies shown in this 
study indicate that binding of either mAb to CD20 increased 
B  lymphoblast Ca  2+ current.  1F5  mAb binding to  CD20 
acutely increased Ca  2+  conductance (within 2  rain).  The 
ability of 1F5 mAb to activate dense tonsillar B lymphocytes 
(10) is consistent with the finding that Ca  ~+ influx is required 
for B lymphocyte activation (28).  The 1F5 mAb-induced in- 
crease in Ca  2÷ conductance may therefore activate resting B 
lymphocytes by  facilitating  Ca  2+  entry,  similar  to  Ca  2+ 
ionophore-induced activation (28).  In contrast, binding of 
the anti-Bla mAb failed to alter the basal Ca  2+ conductance, 
and coincidentally does not activate resting B lymphocytes 
(50). However, prolonged incubation of B cells with anti-Bla 
mAb did increase both Ca  2+ conductance and steady state 
cytosolic Ca  2+ activity. These findings are consistent with 
the notion that B lineage ceils differentially regulate CD20 
activity as a function of cell cycle progression. Also, steady 
state cytosolic Ca  2÷ activity decreased as synchronized B 
lymphoblasts progressed beyond G~-S of the cell cycle in 
the absence of  anti-Bla mAb. However, after incubation with 
anti-Bla, the CD20-associated Ca  2+ current increased and 
the cytosolic Ca  2+ activity remained elevated. The different 
biological effects of the anti-Bla and 1F5 mAb imply that 
mAb-indueed alterations of the endogenous regulation of 
CD20 affect plasma membrane Ca  2+ conductance as well as 
cytosolic Ca  2+ homeostasis in B lineage cells. 
Many channels are regulated by conformational changes 
that result in opened or closed channels, suggesting that the 
binding of the anti-CD20 mAb may affect the conformation 
of  the CD20 subunits. The binding of 1F5 mAb to CD20 may 
mimic the effect of a modulatory ligand to induce structural 
changes in CD20 which in turn results in the formation of 
a conductive configuration of the protein/complex. In con- 
trast, anti-Bla mAb binding appears to stabilize the CD20- 
mediated Ca  2+ conductance, but the mAb does not have the 
ability to acutely enhance the conductance. Similar findings 
have been described with the acetylcholine receptor/channel 
where molecules that mimic acetylcholine (agonists) stabi- 
lize the channel in the open position while those that an- 
tagonize acetylcholine stabilize the channel in a closed posi- 
tion (9).  The direct effects  of anti-Bla and  1F5  mAb on 
CD20-associated Ca  2+ currents are consistent with the hy- 
pothesis that CD20 functions as a Ca  ~+ channel. Although 
future studies will focus on the purification of the CD20 pro- 
tein and its reconstitution into artificial cell membranes, 
expression of the CD20 protein in ectopic cell types as de- 
scribed in this study directly implicates CD20 in the regula- 
tion of transmembrane Ca  2+ conductance in B lymphocytes. 
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